Polaris Venture Management Co. V as of Dec. 31, 2016
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 9 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Selecta Biosciences (RNAC) | 39.2 | $33M | 1.9M | 17.15 | |
| Trevena | 14.3 | $12M | 2.1M | 5.88 | |
| T2 Biosystems | 11.7 | $9.9M | 1.9M | 5.26 | |
| Genocea Biosciences | 9.6 | $8.1M | 2.0M | 4.12 | |
| Ocular Therapeutix (OCUL) | 7.8 | $6.6M | 789k | 8.37 | |
| Fate Therapeutics (FATE) | 7.4 | $6.2M | 2.5M | 2.51 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 4.7 | $3.9M | 1.8M | 2.15 | |
| Cerulean Pharma | 2.8 | $2.3M | 3.3M | 0.71 | |
| Pulmatrix | 2.5 | $2.1M | 3.6M | 0.59 |
